货号: CL-0197
Price: ¥1500 ¥1500
生长培养基: DMEM/F12[PM150312]+5 μg/mL Insulin[PB180432]+10% FBS[164210]+1% P/S[PB180120]
产品信息
产品名称 | RL95-2(人子宫内膜癌细胞) |
别称 | RL-95-2; RL-952; RL952; RL95 |
生长特性 | 贴壁细胞 |
细胞形态 | 上皮细胞样 |
冻存条件 |
冻存液:55% 基础培养基+40% FBS+5% DMSO 温度:液氮 |
培养方案A(默认) |
生长培养基:DMEM/F12[PM150312]+5 μg/mL Insulin[PB180432]+10% FBS[164210]+1% P/S[PB180120] 培养条件: 气相:空气,95%;CO₂,5%, 温度:37℃ |
培养方案B(可选) |
生长培养基: 培养条件: 气相:, 温度:37℃ |
推荐传代比例 | 1:2-1:3 |
推荐换液频率 | 2-3次/周 |
参考资料(来源文献)
背景描述 | RL95-2细胞有α角蛋白,定义明确的连接复合体,张力丝和表面微绒毛。 |
年龄(性别) | 65Y Female |
组织来源 | 器官:子宫;组织:内膜;疾病:癌 |
细胞类型 | 肿瘤细胞 |
肿瘤类型 | 子宫内膜癌 |
生物安全等级 | BSL-1 |
受体表达情况 | estrogen receptor, positive |
STR位点信息
STR鉴定图
-
IGFBP?rP1 affects the proliferation, apoptosis and macrophage polarization of endometrial cancer cells by regulating the PI3K/AKT pathway(2023)
作者:Juan Gao, Shiqi Suo, Jingxia Li, Chunxia Wang, Ranran Deng, Yuxia Hu, Chunzheng Zhang
期刊:Experimental and Therapeutic Medicine
影响因子:2.7
引用产品: Ishikawa 细胞, HEC-1-A 细胞, RL95-2 细胞, HEC-1-B 细胞, AN3 CA 细胞, THP-1 细胞
-
Friend leukemia integration 1 overexpression decreases endometrial receptivity and induces embryo implantation failure by promoting PART1 transcription in the endometrial epithelial cells(2023)
作者:Yile Zhang, Beining Yin, Sichen Li, Yueyue Cui, Jianrong Liu
期刊:PeerJ
影响因子:2.7
引用产品: HEC-1-A 细胞, Ishikawa 细胞, RL95-2 细胞, BeWo 细胞
-
Pan-cancer Analysis Reveals Cancer-dependent Expression of SOX17 and Associated Clinical Outcomes(2023)
作者:LI XU, YOUHUANG BAI, YIHANG CHENG, XIUJIE SHENG, DEQIANG SUN
期刊:Cancer Genomics & Proteomics
影响因子:2.5
引用产品: RL95-2 细胞, DMEM/F12 培养基
-
LINC01857 Exacerbates the Malignant Behaviors of Endometrial Carcinoma Cells by Sponging miR-19b-3p and Recruiting ELAVL1 to Upregulate MYCN(2023)
作者:Cao Rong, Zhao Jiao, Zhang Jingru
期刊:GYNECOLOGIC AND OBSTETRIC INVESTIGATION
影响因子:2.1
引用产品: HEC-1-A 细胞, HEC-1-B 细胞, Ishikawa 细胞, RL95-2 细胞
-
The potential role of methyltransferase-like 5 in deficient mismatch repair of uterine corpus endometrial carcinoma(2022)
作者:Xiaojuan Liu, Hui Ma, Lisha Ma
期刊:Bioengineered
DOI:10.1080/21655979.2022.2036912
影响因子:4.9
引用产品: 人子宫内膜上皮细胞, KLE 细胞, RL95-2 细胞, Ishikawa 细胞
-
Circ_0075960 targets the miR-202-5p/CTNND1 axis to promote the growth and migration of endometrial carcinoma cells via regulating Wnt/β-catenin signaling activity(2022)
作者:Yan Nian, Xiaorong Li, Jingwen Ma, Ting Gao, Dan Liu
期刊:Journal of Gynecologic Oncology
影响因子:4.8
引用产品: HEC-1-B 细胞, 特级胎牛血清, 人子宫内膜基质细胞, DMEM高糖 培养基, Ishikawa 细胞, RL95-2 细胞
-
GLP1R inhibits the progression of endometrial carcinoma through activation of cAMP/PKA pathway(2022)
作者:Wu Li, Yanpin Gu, Songjun Liu, Fan Ruan, Wen Lv
期刊:JOURNAL OF CLINICAL LABORATORY ANALYSIS
影响因子:3.1
引用产品: 人子宫内膜上皮细胞, Ishikawa 细胞, RL95-2 细胞, 人子宫内膜上皮细胞完全培养基, DMEM高糖 培养基, 特级胎牛血清, 青霉素-链霉素溶液 (双抗),100×
-
Lidocaine inhibits the proliferation and migration of endometrial cancer cells, and promotes apoptosis by inducing autophagy(2022)
作者:Dingde Long, Yayu Chen, Liangchao Qu, Yang Dong
期刊:Oncology Letters
影响因子:3.1
-
Circ_0039569 contributes to the paclitaxel resistance of endometrial cancer via targeting miR-1271-5p/PHF6 pathway(2022)
作者:Li Jia, Zhang Zhidong, Hu Yuanjing, Wei Qing, Shao Xuecheng
期刊:ANTI-CANCER DRUGS
DOI:10.1097/CAD.0000000000001377
影响因子:2.4
引用产品: Ishikawa 细胞, RL95-2 细胞, 人子宫内膜基质细胞
-
In situ delivery of apoptotic bodies derived from mesenchymal stem cells via a hyaluronic acid hydrogel: A therapy for intrauterine adhesions(2021)
作者:Liaobing Xin, Cheng Wei, Xiaomei Tong
期刊:Bioactive Materials
DOI:10.1016/j.bioactmat.2021.10.025
影响因子:18.9
引用产品: Ishikawa 细胞, RL95-2 细胞, PUMC-HUVEC-T1
-
Q1:为什么我看的文献里的细胞培养条件和你们官网的培养条件不一样呢?
部分细胞是会出现多种培养条件的,我们公司优先选择引种来源的培养条件以及建系者所用培养条件,出现差异的原因是不同实验室在保藏过程中更改了细胞的培养条件,为了避免细胞突然更换培养条件后不适应,建议您优先使用厂家推荐的培养条件培养。

识别码示意图